drugset

drugset / Trial / NCT01668199

A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

NCT01668199 ↗

Phase 1 Completed 6 enrolled Norgine

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study to investigate the mass balance recovery and pharmacokinetics of 14C TZP-101.

Timeline

Start: 2012-02
Primary completion: 2012-02
Completion: 2012-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ulimorelin	Small molecule	—	—

Indications